Cargando…
Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy
OBJECTIVES: MRI-only radiotherapy (RT) provides a workflow to decrease the geometric uncertainty introduced by the image registration process between MRI and CT data and to streamline the RT planning. Despite the recent availability of validated synthetic CT (sCT) methods for the head region, there...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784680/ https://www.ncbi.nlm.nih.gov/pubmed/35083159 http://dx.doi.org/10.3389/fonc.2021.812643 |
_version_ | 1784638793036333056 |
---|---|
author | Lerner, Minna Medin, Joakim Jamtheim Gustafsson, Christian Alkner, Sara Olsson, Lars E. |
author_facet | Lerner, Minna Medin, Joakim Jamtheim Gustafsson, Christian Alkner, Sara Olsson, Lars E. |
author_sort | Lerner, Minna |
collection | PubMed |
description | OBJECTIVES: MRI-only radiotherapy (RT) provides a workflow to decrease the geometric uncertainty introduced by the image registration process between MRI and CT data and to streamline the RT planning. Despite the recent availability of validated synthetic CT (sCT) methods for the head region, there are no clinical implementations reported for brain tumors. Based on a preceding validation study of sCT, this study aims to investigate MRI-only brain RT through a prospective clinical feasibility study with endpoints for dosimetry and patient setup. MATERIAL AND METHODS: Twenty-one glioma patients were included. MRI Dixon images were used to generate sCT images using a CE-marked deep learning-based software. RT treatment plans were generated based on MRI delineated anatomical structures and sCT for absorbed dose calculations. CT scans were acquired but strictly used for sCT quality assurance (QA). Prospective QA was performed prior to MRI-only treatment approval, comparing sCT and CT image characteristics and calculated dose distributions. Additional retrospective analysis of patient positioning and dose distribution gamma evaluation was performed. RESULTS: Twenty out of 21 patients were treated using the MRI-only workflow. A single patient was excluded due to an MRI artifact caused by a hemostatic substance injected near the target during surgery preceding radiotherapy. All other patients fulfilled the acceptance criteria. Dose deviations in target were within ±1% for all patients in the prospective analysis. Retrospective analysis yielded gamma pass rates (2%, 2 mm) above 99%. Patient positioning using CBCT images was within ± 1 mm for registrations with sCT compared to CT. CONCLUSION: We report a successful clinical study of MRI-only brain radiotherapy, conducted using both prospective and retrospective analysis. Synthetic CT images generated using the CE-marked deep learning-based software were clinically robust based on endpoints for dosimetry and patient positioning. |
format | Online Article Text |
id | pubmed-8784680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87846802022-01-25 Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy Lerner, Minna Medin, Joakim Jamtheim Gustafsson, Christian Alkner, Sara Olsson, Lars E. Front Oncol Oncology OBJECTIVES: MRI-only radiotherapy (RT) provides a workflow to decrease the geometric uncertainty introduced by the image registration process between MRI and CT data and to streamline the RT planning. Despite the recent availability of validated synthetic CT (sCT) methods for the head region, there are no clinical implementations reported for brain tumors. Based on a preceding validation study of sCT, this study aims to investigate MRI-only brain RT through a prospective clinical feasibility study with endpoints for dosimetry and patient setup. MATERIAL AND METHODS: Twenty-one glioma patients were included. MRI Dixon images were used to generate sCT images using a CE-marked deep learning-based software. RT treatment plans were generated based on MRI delineated anatomical structures and sCT for absorbed dose calculations. CT scans were acquired but strictly used for sCT quality assurance (QA). Prospective QA was performed prior to MRI-only treatment approval, comparing sCT and CT image characteristics and calculated dose distributions. Additional retrospective analysis of patient positioning and dose distribution gamma evaluation was performed. RESULTS: Twenty out of 21 patients were treated using the MRI-only workflow. A single patient was excluded due to an MRI artifact caused by a hemostatic substance injected near the target during surgery preceding radiotherapy. All other patients fulfilled the acceptance criteria. Dose deviations in target were within ±1% for all patients in the prospective analysis. Retrospective analysis yielded gamma pass rates (2%, 2 mm) above 99%. Patient positioning using CBCT images was within ± 1 mm for registrations with sCT compared to CT. CONCLUSION: We report a successful clinical study of MRI-only brain radiotherapy, conducted using both prospective and retrospective analysis. Synthetic CT images generated using the CE-marked deep learning-based software were clinically robust based on endpoints for dosimetry and patient positioning. Frontiers Media S.A. 2022-01-10 /pmc/articles/PMC8784680/ /pubmed/35083159 http://dx.doi.org/10.3389/fonc.2021.812643 Text en Copyright © 2022 Lerner, Medin, Jamtheim Gustafsson, Alkner and Olsson https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Lerner, Minna Medin, Joakim Jamtheim Gustafsson, Christian Alkner, Sara Olsson, Lars E. Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy |
title | Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy |
title_full | Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy |
title_fullStr | Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy |
title_full_unstemmed | Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy |
title_short | Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy |
title_sort | prospective clinical feasibility study for mri-only brain radiotherapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784680/ https://www.ncbi.nlm.nih.gov/pubmed/35083159 http://dx.doi.org/10.3389/fonc.2021.812643 |
work_keys_str_mv | AT lernerminna prospectiveclinicalfeasibilitystudyformrionlybrainradiotherapy AT medinjoakim prospectiveclinicalfeasibilitystudyformrionlybrainradiotherapy AT jamtheimgustafssonchristian prospectiveclinicalfeasibilitystudyformrionlybrainradiotherapy AT alknersara prospectiveclinicalfeasibilitystudyformrionlybrainradiotherapy AT olssonlarse prospectiveclinicalfeasibilitystudyformrionlybrainradiotherapy |